Good morning :)
IOL Chemicals and Pharmaceuticals Ltd

IOL Chemicals and Pharmaceuticals Ltd

IOLCP Share Price

NSE
73.051.31% (-0.97)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹2,144 cr, stock is ranked 1,122

Stock is 3.84x as volatile as Nifty

IOLCP Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹2,144 cr, stock is ranked 1,122

Stock is 3.84x as volatile as Nifty

IOLCP Performance & Key Metrics

IOLCP Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
18.501.271.10%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
29.623.391.49%

IOLCP Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 1 analyst

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

IOLCP Company Profile

IOL Chemicals and Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged in manufacturing and selling of organic chemicals and bulk drugs.

Investor Presentation

View older View older 

Feb 12, 2026

PDF
View Older Presentations

IOLCP Similar Stocks (Peers)

Compare with peers Compare with peers 

IOLCP Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
101.04
101.04
1Y Return
54.80%
54.80%
Buy Reco %
88.89
88.89
LINDEINDIA
PE Ratio
126.19
126.19
1Y Return
10.91%
10.91%
Buy Reco %
50.00
50.00
PE Ratio
44.03
44.03
1Y Return
14.95%
14.95%
Buy Reco %
0.00
0.00
PE Ratio
30.92
30.92
1Y Return
16.12%
16.12%
Buy Reco %
50.00
50.00
PE Ratio
39.61
39.61
1Y Return
15.48%
15.48%
Buy Reco %
85.71
85.71
Compare with Peers

IOLCP Sentiment Analysis

IOLCP Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

IOLCP Stock Summary · February 2026

In Q3 FY '26, the company showcased resilience through a diversified business model, achieving a 10.9% revenue increase driven by strong performance in both pharmaceuticals and chemicals, despite facing challenges like rising fuel costs and a one-time exceptional loss from labor law changes. Operational efficiency remains a priority, with the chemicals division operating near full capacity, while strategic initiatives focus on expanding high-value APIs and entering regulated markets in Europe and MENA. Although EBITDA margins have been pressured by pricing strategies and underutilization, management remains optimistic about future growth, targeting INR 600 crores in revenue for Q4 and emphasizing the importance of R&D and product development to enhance market positioning.

IOLCP Stock Growth Drivers
IOLCP Stock Growth Drivers
7
  • Strong Financial Performance

    In Q3 FY '26, the company reported a revenue increase of 10.9% year-on-year, reaching INR

  • Resilience Amid Challenges

    The company demonstrated resilience in its operations during Q3 FY '26, effectively navigating global geopolitical

IOLCP Stock Challenges
IOLCP Stock Challenges
5
  • Declining Profit Margins

    The company has experienced a sequential decline in pharma EBIT margins from 10.5% to approximately

  • Exceptional Financial Losses

    The company reported a one-time exceptional loss of approximately INR 11 crores due to changes

IOLCP Forecast

IOLCP Forecasts

Price

Revenue

Earnings

IOLCP

IOLCP

Income

Balance Sheet

Cash Flow

IOLCP Income Statement

IOLCP Income Statement

Loading...

Quartersep 2023dec 2023mar 2024jun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025
Total Revenue552.41528.77511.44509.76532.18527.37532.30559.06574.41585.68
Operating & Other expensessubtract481.10476.04454.40451.27484.18476.43465.02489.55510.45534.32
Depreciation/Amortizationsubtract15.6916.3416.4316.8217.9418.6818.5519.7719.9920.18
Interest & Other Itemssubtract4.444.303.412.154.124.464.034.233.483.63
Taxes & Other Itemssubtract13.319.019.589.556.797.2713.2811.5810.526.97
EPS1.290.790.941.020.650.701.071.161.020.70

IOLCP Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2026FY 2026

Annual Report Pending

Investor Presentation

Feb 12PDF
Nov 12PDF
Aug 7PDF
FY 2025FY 2025

Annual report

PDF

Investor Presentation

May 19PDF
Feb 13PDF
Nov 18PDF
FY 2024FY 2024

Annual report

PDF

Investor Presentation

Aug 14PDF
FY 2023FY 2023

Annual report

PDF

Investor Presentation

May 8PDF
Feb 8PDF
Nov 15PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
 

IOLCP Stock Peers

IOLCP Past Performance & Peer Comparison

IOLCP Past Performance & Peer Comparison

Comparing 3 stocks from 
MaterialsCommodity Chemicals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
IOL Chemicals and Pharmaceuticals Ltd21.221.271.10%
Solar Industries India Ltd101.0426.860.07%
Linde India Ltd126.1915.030.18%
Himadri Speciality Chemical Ltd44.036.490.12%

IOLCP Stock Price Comparison

Compare IOLCP with any stock or ETF
Compare IOLCP with any stock or ETF
IOLCP
Loading...

IOLCP Holdings

IOLCP Shareholdings

IOLCP Promoter Holdings Trend

IOLCP Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

IOLCP Institutional Holdings Trend

IOLCP Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

IOLCP Shareholding Pattern

IOLCP Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding52.62%0.02%0.01%2.08%45.27%

Mar 2025

Jun 2025

Sep 2025

Dec 2025

IOLCP Shareholding History

IOLCP Shareholding History

SepDec '24MarJunSepDec '251.63%1.49%1.47%2.59%2.25%2.08%

Mutual Funds Invested in IOLCP

Mutual Funds Invested in IOLCP

No mutual funds holding trends are available

Top 2 Mutual Funds holding IOL Chemicals and Pharmaceuticals Ltd



Funds (Top 2)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
0.0005%0.07%-0.01%86/123 (-3)
0.0001%0.00%-0.00%844/1038 (-4)

Compare 3-month MF holding change on Screener

IOLCP Insider Trades & Bulk Stock Deals

IOLCP Insider Trades & Bulk Stock Deals

Loading...

smallcases containing IOLCP stock

smallcases containing IOLCP stock

Looks like this stock is not in any smallcase yet.

IOLCP Events

IOLCP Events

IOLCP Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

IOLCP Dividend Trend

No dividend trend available

IOLCP Upcoming Dividends

IOLCP Upcoming Dividends

No upcoming dividends are available

IOLCP Past Dividends

IOLCP Past Dividends

Cash Dividend

Ex DateEx DateFeb 17, 2026

Interim
Interim | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Feb 17, 2026

Cash Dividend

Ex DateEx DateFeb 18, 2025

Interim
Interim | Div/Share: ₹4.00

Dividend/Share

4.00

Ex DateEx Date

Feb 18, 2025

Cash Dividend

Ex DateEx DateFeb 16, 2024

Interim
Interim | Div/Share: ₹5.00

Dividend/Share

5.00

Ex DateEx Date

Feb 16, 2024

Cash Dividend

Ex DateEx DateFeb 17, 2023

Interim
Interim | Div/Share: ₹4.00

Dividend/Share

4.00

Ex DateEx Date

Feb 17, 2023

Cash Dividend

Ex DateEx DateFeb 15, 2022

Interim
Interim | Div/Share: ₹4.00

Dividend/Share

4.00

Ex DateEx Date

Feb 15, 2022

IOLCP Stock News & Opinions

IOLCP Stock News & Opinions

Earnings
IOL Chemicals & Pharmaceuticals consolidated net profit rises 0.24% in the December 2025 quarter

Net profit of IOL Chemicals & Pharmaceuticals rose 0.24% to Rs 20.58 crore in the quarter ended December 2025 as against Rs 20.53 crore during the previous quarter ended December 2024. Sales rose 10.91% to Rs 580.39 crore in the quarter ended December 2025 as against Rs 523.30 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales580.39523.30 11 OPM %9.878.96 - PBDT58.9446.48 27 PBT38.7627.80 39 NP20.5820.53 0 Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Corporate
Board of IOL Chemicals & Pharmaceuticals recommends interim dividend

IOL Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 11 February 2026, inter alia, have recommended the interim dividend of Rs 1 per equity Share (i.e. 50%) , subject to the approval of the shareholders.Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Corporate
IOL Chemicals & Pharmaceuticals to discuss results

IOL Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
IOL Chemicals & Pharmaceuticals consolidated net profit rises 56.50% in the September 2025 quarter

Net profit of IOL Chemicals & Pharmaceuticals rose 56.50% to Rs 29.97 crore in the quarter ended September 2025 as against Rs 19.15 crore during the previous quarter ended September 2024. Sales rose 7.95% to Rs 567.53 crore in the quarter ended September 2025 as against Rs 525.75 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales567.53525.75 8 OPM %10.067.91 - PBDT60.4843.88 38 PBT40.4925.94 56 NP29.9719.15 57 Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
IOL Chemicals & Pharmaceuticals schedules board meeting

IOL Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
IOL Chemicals receives CEP certificate for Sitagliptin Phosphate Monohydrate

IOL Chemicals & Pharmaceuticals announced that the European Directorate for the Quality of Medicines & Health Care (EDQM) has issued a Certificate of Suitability for Company's API product 'Sitagliptin Phosphate Monohydrate' on 27 October 2025. Sitagliptin Phosphate Monohydrate is an oral antidiabetic medication used to control high blood sugar levels. Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
IOL Chemicals & Pharmaceuticals consolidated net profit rises 13.21% in the June 2025 quarter

Net profit of IOL Chemicals & Pharmaceuticals rose 13.21% to Rs 33.93 crore in the quarter ended June 2025 as against Rs 29.97 crore during the previous quarter ended June 2024. Sales rose 9.82% to Rs 551.69 crore in the quarter ended June 2025 as against Rs 502.38 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales551.69502.38 10 OPM %11.2610.17 - PBDT65.2856.34 16 PBT45.5139.52 15 NP33.9329.97 13 Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
IOL Chemicals & Pharmaceuticals to convene board meeting

IOL Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 August 2025.Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
IOL Chemicals & Pharmaceuticals to conduct AGM

IOL Chemicals & Pharmaceuticals announced that the 38th Annual General Meeting(AGM) of the company will be held on 22 August 2025.Powered by Capital Market - Live

9 months agoCapital Market - Live
Earnings
IOL Chemicals & Pharmaceuticals consolidated net profit rises 13.76% in the March 2025 quarter

Net profit of IOL Chemicals & Pharmaceuticals rose 13.76% to Rs 31.42 crore in the quarter ended March 2025 as against Rs 27.62 crore during the previous quarter ended March 2024. Sales rose 4.73% to Rs 527.78 crore in the quarter ended March 2025 as against Rs 503.92 crore during the previous quarter ended March 2024. For the full year,net profit declined 24.82% to Rs 101.07 crore in the year ended March 2025 as against Rs 134.43 crore during the previous year ended March 2024. Sales declined 2.51% to Rs 2079.21 crore in the year ended March 2025 as against Rs 2132.79 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales527.78503.92 5 2079.212132.79 -3 OPM %11.899.83 -9.7310.81 - PBDT63.2553.63 18 209.95244.56 -14 PBT44.7037.20 20 137.96181.65 -24 NP31.4227.62 14 101.07134.43 -25 Powered by Capital Market - Live

9 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) today?

    The share price of IOLCP as on 27th February 2026 is ₹73.05. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on IOL Chemicals and Pharmaceuticals Ltd (IOLCP) share?

    The past returns of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) share are
    • Past 1 week: -1.32%
    • Past 1 month: 5.96%
    • Past 3 months: -19.60%
    • Past 6 months: -19.65%
    • Past 1 year: 11.80%
    • Past 3 years: 25.73%
    • Past 5 years: -33.40%

  3. What are the peers or stocks similar to IOL Chemicals and Pharmaceuticals Ltd (IOLCP)?
  4. What is the dividend yield % of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) share?

    The current dividend yield of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) is 1.10.

  5. What is the market cap of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) is ₹2144.22 Cr as of 27th February 2026.

  6. What is the 52 week high and low of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) share?

    The 52-week high of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) is ₹126.66 and the 52-week low is ₹57.50.

  7. What is the PE and PB ratio of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) stock?

    The P/E (price-to-earnings) ratio of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) is 21.22. The P/B (price-to-book) ratio is 1.27.

  8. Which sector does IOL Chemicals and Pharmaceuticals Ltd (IOLCP) belong to?

    IOL Chemicals and Pharmaceuticals Ltd (IOLCP) belongs to the Materials sector & Commodity Chemicals sub-sector.

  9. How to buy IOL Chemicals and Pharmaceuticals Ltd (IOLCP) shares?

    You can directly buy IOL Chemicals and Pharmaceuticals Ltd (IOLCP) shares on Tickertape. Simply sign up, connect your demat account and place your order.